Evaluate the effectiveness of ondansetron in treating the vommiting for children < 5 years OLD with acute gastroenteritis at pediatrics department, HUE central hospital
Abstract
Background: To control the vommit symptom give more successful and easier to oral fluid infusion, reduce the cost and work if using IV infusion. All over the world there are many studies on using Ondansetron for vommint preventing in gastroenteritis in children and show the effectiveness and safety. At Hue, Ondansetron mainly use for vommit preventing for children patients treated by chemotherapy and radiotherapy. There was no study about using Ondansetron to vommit preventing and treating for children patients with acute gastroenteritis. The aim of this study is to evaluate the effectiveness of Ondansetron in vommit treating for children with acute gastroenteritis. Population and study methods: children from 6 mths to 5yrs with acute gastroenteritis at Pediatric department of Hue Central Hospital. Using the method of clinical intervention with control group. 2 groups had the similarity of age, gender, onset duration of vommit, dehydration situation. Sample size: 86 children in control group and 41 children for study group. Study group with intervention) : only one shoot Ondansetron 0,2mg/kg + treatment plan fordedration + Zinc suppement as IMCI guidelines. Control group: treating by treatment plan for dehydration + Zinc suppement as IMCI guidelines. Both two groups will follow up about the situation of vommit, watery stools and the amount of ORS, the amount of IV fluid. Result: The rate of patient without vommit in the time from intervention to hospital discharge: Group…
Read the paper
Related studies
- Patient-Centered Pharmaceutical Design to Improve Acceptability of Medicines: Similarities and Differences in Paediatric and Geriatric Populations
- Evidence-based clinical practice guidelines for irritable bowel syndrome 2020
- Phase 2b Study of Pimodivir (JNJ-63623872) as Monotherapy or in Combination With Oseltamivir for Treatment of Acute Uncomplicated Seasonal Influenza A: TOPAZ Trial
- Gastrointestinal manifestations in COVID-19
- COVID-19 and Gastrointestinal Disease: Implications for the Gastroenterologist
- Persistent gut barrier damage and commensal bacterial influx following eradication of Giardia infection in mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.